Assisted Reproductive Medicine in China

The rapid development in China has given young people more opportunities to develop themselves. As a result, the infertility rate among Chinese couples (who want to have children) is increasing. The reason is the delay of the chosen childbearing age. With the introduction of the two-child policy, Chinese couples' demand for assisted reproductive technology is continuously increasing, creating a correspondingly large market. China will continue to lead the global assisted reproduction market.

Swiss International Health Care has partnered with renowned European and Chinese organizations to jointly establish its own brand of assisted reproductive medicine and a state-of-the-art cryobank for egg, sperm, ovarian and testicular tissue in China.



Swiss International Health Care GmbH

Winkelriedstrasse 82
8203 Schaffhausen

Legal information

Social Media